Cryopreservation: Clinical Trials

3 trials of Cryopreservation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Not yet recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Cryopreservation: new trials by email Literature Review of Cryopreservation trials Research Report on Cryopreservation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)
CK0802 (Allogeneic, Cryopreserved, Cord blood-derived T-regulatory cells, cells that are not HLA matched) - Steroid Refractory Graft Versus Host Disease
Phase 1 / Phase 2Not yet recruitingCellenkos, Inc.122026-11-012026-10-21
QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
M-CENK, Suspension for Infusion, Cryopreserved (M-CENK) (Cohort 2 part B), N-803 (Cohort 2 part B), Apheresis collection of MNCs (part A) - Metastatic Solid Tumor
Phase 1Active not recruitingImmunityBio, Inc.502021-06-212026-11-02
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
TCM allogeneic humane central memory T cells, cryopreserved - Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Phase 1 / Phase 2CompletedWuerzburg University Hospital162016-04-012022-07-13

Conditions studied

Graft vs Host Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)

Sponsors

Cellenkos, Inc. (1)  ·  ImmunityBio, Inc. (1)  ·  Wuerzburg University Hospital (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Leonard Sender, MD (1)

NIH funding

2015 (1)